Skip to main content
. 2021 Mar 18;65(4):e02392-20. doi: 10.1128/AAC.02392-20

TABLE 6.

Metabolite production/incorporation in untreated and fosmidomycin-treated parasites

Metabolite Total synthesized amount (mmol/gDW)a
Δm=vFOStvCTLt
t=048vCTLt t=048vtFOS
Spermidine 52.8 120.2 2.28
Coenzyme A 39.4 62.2 1.58
Fe3+ 32.3 46.2 1.43
Nicotinamide adenine dinucleotide oxidized 28.3 38.1 1.35
Flavin adenine dinucleotide oxidized 44.7 51.3 1.15
Putrescine 33.8 37.9 1.12
Fe2+ 47.0 47.0 1.00
SO42 47.4 47.1 0.99
5,10-Methylenetetrahydrofolate 61.6 60.7 0.98
Thiamine diphosphate 46.4 44.8 0.97
S-Adenosylmethionine 348.1 318.2 0.91
10-Formyltetrahydrofolate 43.1 39.2 0.91
Riboflavin 55.3 47.0 0.85
Ubiquinol 46.1 38.5 0.83
NH4+ 259.7 200.9 0.77
5,6,7,8-Tetrahydrofolate 75.2 46.3 0.62
Protoheme 210.6 129.3 0.61
Nicotinamide adenine dinucleotide phosphate 122.5 47.40 0.39
Pyridoxal 5-phosphate 219.9 40.69 0.19
PO43 462.0 68.72 0.15
Macromolecule Total synthesized amount (g/gDW) Δm
DNA 0.9 1.0 1.16
RNA 6.6 5.1 0.78
Protein 21.2 15.8 0.74
Phospholipid 2.8 1.8 0.64
a

The total accumulated amount of a metabolite (or macromolecule) was computed by numerically integrating the synthesis rate (v) of each metabolite over the 48-h intraerythrocytic developmental cycle under control (CTL) or fosmidomycin (FOS)-treated conditions. Abbreviation: gDW, grams dry weight of the parasite.